Patent · US Active

Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

US9555007B2 · kind B2 · utility

5Cited by
21References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 14, 2013
Grant dateJan 31, 2017
Priority date
Expiry dateMar 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2035/128
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Biocompatible hydrogel capsules encapsulating mammalian cells having a diameter of greater than 1 mm, and optionally a cell free core, are disclosed which have reduced fibrotic overgrowth after implantation in a subject. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.